TITLE

T4 Rectal Cancer: Analysis of Patient Outcome After Surgical Excision

AUTHOR(S)
Amshel, Craig; Avital, Shmuel; Miller, Allison; Sands, Laurence; Marchetti, Floriano; Hellinger, Michael
PUB. DATE
November 2005
SOURCE
American Surgeon;Nov/2005, Vol. 71 Issue 11, p901
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Locally advanced rectal cancer dictates a major surgical undertaking, which includes en bloc resection of the rectum and all involved organs. The aim of this study was to evaluate patient outcome and compare multimodality treatment options after various surgical approaches from one institution for T4 rectal cancer. A retrospective chart review identified 24 patients who were operated on for advanced primary rectal cancer invading adjacent structures (T4) over a 5 1/2-year period. The types of treatment and outcome were analyzed. From these 24 patients, the most frequently involved organ was the bladder (33%). A total of 16 patients underwent chemoradiotherapy. There were 12 complications (50%), the most common being wound infection (33% of complications, 17% overall). Nine patients had nodal disease. Disease-free survival was 54 per cent, and overall survival was 75 per cent. However, disease-free survival in node-negative patients was 67 per cent versus 33 per cent in node-positive individuals. Out of the six patients who died in this review, five (83%) received chemoradiotherapy. Operations for advanced primary rectal cancer with involvement of adjacent organs are major procedures associated with high morbidity. Patients without nodal disease may have long-term survival despite the locally advanced tumor. Interestingly, neoadjuvant therapy, adjuvant, or both, did not increase survival.
ACCESSION #
18903999

 

Related Articles

  • Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer—a review focusing on open questions. Moser, Lutz; Ritz, Jörg-Peter; Hinkelbein, Wolfgang; Höcht, Stefan // International Journal of Colorectal Disease;Mar2008, Vol. 23 Issue 3, p227 

    The therapy of rectal cancer has been a matter of debate since decades, especially with regard to the benefits of neoadjuvant or adjuvant therapies. Principles of additional therapies have been established nearly two decades ago and are questioned nowadays on the basis of more recently modified...

  • Marges d’exérèse et qualité de prise en charge des cancers du rectum. Le Tinier, F.; Jafari, M.; Mirabel, X.; Vanseymortier, L. // Oncologie;Jan2010, Vol. 12 Issue 1, p34 

    La prise en charge du cancer du rectum s’est considérablement améliorée ces derniéres années avec l’émergence de nouvelles techniques chirurgicales et la place croissante des traitements néoadjuvants. De plus, de nouveaux facteurs pronostiques comme la marge...

  • GIST: advances in tyrosine kinase inhibitors enhance laparoscopic resection even in advanced disease. Hottenrott, Christof // Surgical Endoscopy;Apr2013, Vol. 27 Issue 4, p1446 

    The article reports on the targeted cancer therapy of gastrointestinal stromal tumors (GIST) and prime paradigm of how laparoscopic GIST surgical resection and adjuvant treatment. It states that the large series of excellent short-term and oncological outcomes associated with laparoscopic...

  • Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients. Ji Zhu; Ye Xu; Weilie Gu; Junjie Peng; Gang Cai; Guoxiang Cai; Wenjie Sun; Weiqi Shen; Sanjun Cai; Zhen Zhang // Radiation Oncology;2010, Vol. 5, p118 

    Background: Adjuvant therapy for T3N0 rectal cancer was controversial with respect to both radiation and the use of a combined regimen of chemotherapy. We evaluated both clinical features and biomarkers and sought to determine risk factors for those patients retrospectively. Methods: A total of...

  • Impact of Neoadjuvant Therapy on Postoperative Complications in Patients Undergoing Resection for Rectal Adenocarcinoma. Turner, Immanuel I.; Russell, Gregory B.; Blackstock, A. William; Levine, Edward A. // American Surgeon;Dec2004, Vol. 70 Issue 12, p1045 

    Surgical resection continues to be the mainstay of treatment for rectal cancer. Neoadjuvant therapy (chemotherapy and radiation) has also been shown to be efficacious. The impact of preoperative chemotherapy and radiation on postoperative complications is unclear. The purpose of this study is to...

  • Neoadjuvant and adjuvant radio- and radio-chemotherapy of rectal carcinomas. Påhlman, Lars // International Journal of Colorectal Disease;Jan2000, Vol. 15 Issue 1, p1 

    The objectives in treating rectal cancer are to achieve locoregional tumor control and to prolong overall survival. With surgery alone the reported local failure rates in recent decades have been unacceptably high, and this is associated with substantial morbidity and mortality. Perioperative...

  • Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature. Chadi, Sami; Berho, Marianna; Wexner, Steven // Langenbeck's Archives of Surgery;Aug2015, Vol. 400 Issue 6, p661 

    Background: Despite screening initiatives, rectal cancer remains one of the most prevalent malignancies diagnosed in patients worldwide with a high mortality. The introduction of neoadjuvant therapy has resulted in a paradigm shift in the treatment and outcomes of rectal cancer. Surgeons play an...

  • Strahlentherapieassoziierte Morbidität und Mortalität in der Rektumchirurgie. Kulu, Y.; Büchler, M.W.; Ulrich, A. // Der Chirurg;Nov2013, Vol. 84 Issue 11, p951 

    The treatment of rectal cancer has evolved significantly in recent decades. Both modern radiotherapy treatment concepts and surgical techniques have been able to improve oncological as well as functional outcomes for rectal cancer patients. Large-scale, multicenter, randomized trials have been...

  • Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma Bedrosian, Isabelle; Rodriguez-Bigas, Miguel A.; Feig, Barry; Hunt, Kelly K.; Ellis, Lee; Curley, Steven A.; Vauthey, Jean Nicolas; Delclos, Marc; Crane, Christopher; Janjan, Nora; Skibber, John M. // Journal of Gastrointestinal Surgery;Jan2004, Vol. 8 Issue 1, p56 

    Preoperative chemoradiation therapy (CRT) in patients with locally advanced rectal cancer allows for radical surgery with sphincter preservation in many patients. To determine whether patients downsized with preoperative CRT may be potential candidates for local excision, we investigated...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics